|
| | Publication Year | Title | Author(s) |
| 901 | 17-Dec-2022 | Tumor Growth Remains Refractory to Myc Ablation in Host Macrophages. | Morrow, Riley J; Allam, Amr H; Konecnik, Josh; Baloyan, David; Dijkstra, Christine ; Eissmann, Moritz F ; Jacob, Saumya P; O'Brien, Megan; Poh, Ashleigh R; Ernst, Matthias |
| 902 | Dec-2023 | Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. | Nasir, Ibraheem; McGuinness, Conor; Poh, Ashleigh R; Ernst, Matthias ; Darcy, Phillip K; Britt, Kara L |
| 3 | 10-Jun-2021 | Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. | Lima, Luize G; Ham, Sunyoung; Shin, Hyunku; Chai, Edna P Z; Lek, Erica S H; Lobb, Richard J; Müller, Alexandra F; Mathivanan, Suresh; Yeo, Belinda ; Choi, Yeonho; Parker, Belinda S; Möller, Andreas |
| 4 | 1-Aug-2008 | Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct. | Kelly, Marcus P; Lee, Fook-Thean; Tahtis, Kiki; Power, David Anthony; Smyth, Fiona E; Brechbiel, Martin W; Hudson, Peter J; Scott, Andrew M |
| 5 | 3-Aug-2021 | Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin. | Gan, Hui K ; Parakh, Sagun ; Lassman, Andrew B; Seow, Aidan; Lau, Eddie ; Lee, Sze Ting ; Ameratunga, Malaka; Perchyonok, Yuliya ; Cao, Diana; Burvenich, Ingrid J G; O'Keefe, Graeme J; Rigopoulos, Angela; Gomez, Erica; Maag, David; Scott, Andrew M |
| 6 | 8-Jun-2021 | Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. | Poh, Ashleigh R; Ernst, Matthias |
| 7 | 12-Aug-2004 | The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. | Luwor, Rodney B; Zhu, Hong-Jian; Walker, Francesca; Vitali, Angela A; Perera, Rushika M; Burgess, Antony W; Scott, Andrew M ; Johns, Terrance G |
| 8 | 17-Jul-2013 | Tumor-specific T-cell help is associated with improved survival in melanoma. | Woods, Katherine; Cebon, Jonathan S |
| 9 | Jan-2017 | Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab | Ku, Matthew; Chong, Geoff; Hawkes, Eliza A |
| 10 | Jul-2020 | Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. | Williams, David S ; Mouradov, Dmitri; Newman, Marsali R ; Amini, Elham; Nickless, David K; Fang, Catherine G; Palmieri, Michelle; Sakthianandeswaren, Anuratha; Li, Shan; Ward, Robyn L; Hawkins, Nicholas J; Skinner, Iain; Jones, Ian; Gibbs, Peter; Sieber, Oliver M |
| 11 | Dec-2015 | Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes | Wilmott, James S; Field, Matthew A; Johansson, Peter A; Kakavand, Hojabr; Shang, Ping; De Paoli-Iseppi, Ricardo; Vilain, Ricardo E; Pupo, Gulietta M; Tembe, Varsha; Jakrot, Valerie; Shang, Catherine A; Cebon, Jonathan S ; Shackleton, Mark; Fitzgerald, Anna; Thompson, John F; Hayward, Nicholas K; Mann, Graham J; Scolyer, Richard A |
| 12 | Sep-2016 | The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state | Alhawaiti, Naif; Burbury, Kate L; Kwa, Faith A; O'Malley, Cindy J; Shuttleworth, Peter ; Alzard, Mohamad; Hamadi, Abdullah; Grigg, Andrew P ; Jackson, Denise E |
| 13 | 16-Aug-2022 | Unexpected case of accelerated silicosis in a female quarry worker. | Leong, Tracy L ; Wimaleswaran, Hari ; Williams, David S ; Goh, Nicole S L ; Hoy, Ryan F |
| 14 | Apr-2020 | Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO Congress 2019. | Lau, David K ; Burge, Matthew; Roy, Amitesh; Chau, Ian; Haller, Daniel G; Shapiro, Jeremy D; Peeters, Marc; Pavlakis, Nick; Karapetis, Christos S; Tebbutt, Niall C ; Segelov, Eva; Price, Timothy J |
| 15 | 1-Apr-2022 | Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors. | Demetri, George D; De Braud, Filippo; Drilon, Alexander; Siena, Salvatore; Patel, Manish R; Cho, Byoung Chul; Liu, Stephen V; Ahn, Myung-Ju; Chiu, Chao-Hua; Lin, Jessica J; Goto, Koichi; Lee, Jeeyun; Bazhenova, Lyudmila; John, Thomas ; Fakih, Marwan; Chawla, Sant P; Dziadziuszko, Rafal; Seto, Takashi; Heinzmann, Sebastian; Pitcher, Bethany; Chen, David; Wilson, Timothy R; Rolfo, Christian |
| 16 | 18-May-2021 | Uptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry. | Wong, Vanessa ; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Nottage, Michelle; Gibbs, Peter; Lok, Sheau Wen |
| 17 | 27-Sep-2018 | Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients. | Grigg, Samuel E ; Date, Patrick; Loh, Zoe ; Estacio, Ortis; Johnson, Douglas F; Hawkes, Eliza A ; Grigg, Andrew P |
| 18 | 1-Feb-2000 | Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy. | Hannah, A; Feigen, Malcolm; Quong, George; Akhurst, T; Berlangieri, Salvatore U ; Zimet, A; Zalcberg, John R; McKay, W J; Scott, Andrew M |
| 19 | Feb-2021 | Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. | Loh, Zoe ; Hawkes, Eliza A ; Chionh, Fiona; Azad, Arun; Chong, Geoffrey |
| 20 | 13-Feb-2024 | Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. | Wai, Shin Hnin; Lee, Sze Ting ; Cliff, Edward Robert Scheffer; Bei, Michael; Lee, Jiwoo; Hawkes, Eliza A ; Chong, Geoffrey |
